Tumor heterogeneity, a hallmark of cancer, refers to the presence of diverse cell populations within a tumor. These cells vary in genetic, epigenetic, and phenotypic characteristics, leading to differences in proliferation rates, drug sensitivity, and metastatic potential. Understanding tumor heterogeneity is crucial for developing effective treatment strategies. Techniques like single-cell sequencing and spatial profiling have unveiled the intricate landscape of tumor heterogeneity, revealing subclones and microenvironments that influence disease progression and therapy response. Leveraging this knowledge, researchers aim to personalize cancer treatment by targeting specific tumor cell populations and their associated vulnerabilities. By unraveling the complexity of tumor heterogeneity, scientists strive to improve patient outcomes and pave the way for precision oncology.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States